Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents

Part I. General Pharmacokinetic and Pharmacodynamic Principles of Psychopharmacological Agents

1. Pharmacokinetic Properties
Mark S. Luer, Scott R. Penzak

2. Pharmacodynamics
Carlos H. Rojas-Fernandez

3. Positron Emission Tomography (PET) Use in Pharmacology
Jonathon A. Nye, Leonard Howell

4. Population Pharmacokinetics
Ayyappa Chaturvedula

5. Drug Transporters
Scott R. Penzak

6. Pharmacogenomics
Kristen M. Wiese, Stephanie A. Flowers, Vicki L. Ellingrod

Part II. Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Drug Classes

7. Antipsychotics
Michael W. Jann, W. Klugh Kennedy

8. Mood Stabilizers
Edoardo Spina, Domenico Italiano

9. Antidepressants
Patrick R. Finley, Jennifer Le, Kelly C. Lee

10. Clinical Pharmacokinetics and Pharmacodynamics of Anxiolytics and Sedative/Hypnotics
C. Lindsay DeVane

11. Opioid Analgesics
Sally K. Guthrie, Christian Teter

12. Stimulants and Other Non-stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD)
John S. Markowitz, Guo Yu

13. Antidementia Drugs
Chad M. VanDenBerg, Michael W. Jann

14. Anti-addiction Agents
Michael W. Jann

15. Anesthetic Drugs Pharmacokinetics and Pharmacodynamics
Michael W. Jann

Part III. Clinically Significant Drug Interactions with Psychopharmacological Agents

16. Clinically Significant Interactions with Antipsychotics
Mong-Liang Lu, Hsien-Yuan Lane

17. Clinically Significant Interactions with Mood Stabilisers
David Taylor, Kalliopi Vallianatou

18. Clinically Significant Interactions with Antidepressants
Y. W. Francis Lam

19. Clinically Significant Interactions with Benzodiazepines
Jose Valdes, Douglas L. Boggs, Angela A. Boggs, Jose A. Rey

20. Clinical Significant Interactions with Opioid Analgesics
Tony K. L. Kiang, Mary H. H. Ensom

21. Clinically Significant Interactions with Stimulants and Other Non-stimulants for ADHD
Rania S. Kattura, M. Lynn Crismon

22. Clinically Significant Interactions with Cholinesterase Inhibitors and Other Antidementia Agents
Chad M. VanDenBerg

23. Clinically Significant Interactions with Anti-addiction Agents
Janet K. Coller, Daniel T. Barratt, Andrew A. Somogyi

24. Clinically Significant Interactions with Anesthetic Agents
Michael W. Jann

Nyckelord: Medicine & Public Health, Psychopharmacology, Drug Safety and Pharmacovigilance